About Elegant Drugs Private Limited
Data last updated:
Elegant Drugs Private Limited is a private limited company based in Hubli, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 August 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U02423KA1988PTC009345. Its GSTIN is 29AAACE3971B1ZU (Karnataka).
The company has an authorised share capital of ₹5.2 Cr and a paid-up capital of ₹3.06 Cr. It is led by directors including Rajashekar Channasangappa Pattanashetti (Managing Director) and Seetha Raman Subramaniyam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at R.S. No.59/3A Chalamatti Village Sarwar Road Hubli, Karnataka, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.12 Cr, a growth of 89% compared to the previous year. For the same year it recorded a net loss of ₹3.04 Cr (net margin -73.8%) and EBITDA of -₹2.23 Cr (EBITDA margin -54.2%). Revenue has declined at a compounded annual rate (CAGR) of 52% over three years and 8% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Elegant Drugs. As per MCA filings, the company has open charges of ₹2.6 Cr and satisfied charges of ₹2.21 Cr on record. Court records list 39 cases involving the company, including 24 filed by the company and 15 filed against it; 4 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elegantdrugs.com.
Company details
Contact details
Elegant Drugs Private Limited's registered office is in Hubli, Karnataka. Its website is elegantdrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressR.S. No.59/3A Chalamatti Village Sarwar Road Hubli, Karnataka, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Elegant Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Elegant Drugs operates one associated brand: Elegant Drugs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations manufacturing, including tablets and capsules, with a focus on quality compliance in India. | elegantdrugs.com |
Business activity
The main business activity of Elegant Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Elegant Drugs Private Limited, buy the company report.
Financials of Elegant Drugs Private Limited
FY 2024 filings availableElegant Drugs Private Limited reported revenue of ₹4.12 Cr (up 89% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 89% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 8%. EBITDA fell 172% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -54.2% | ||||
| Net Profit Margin | -73.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elegant Drugs Private Limited, buy the company report.
Board of directors of Elegant Drugs Private Limited
Elegant Drugs has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seetha Raman Subramaniyam | Director | 13 Jan 2022 | 4 Years 9 Months | Current |
| Koteswara Rao Yechuri | Director | 13 Jan 2022 | 4 Years 9 Months | Current |
| Rajashekar Channasangappa Pattanashetti | Managing Director | 24 Dec 1997 | 28 Years 10 Months | Current |
Peer comparison
Elegant Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dales Laboratories P Ltd | ₹4.13 Cr (FY 2025) | -14.0% | Mumbai, Maharashtra, India | |||
| Elegant Drugs Private Limitedthis company | ₹4.12 Cr (FY 2025) | -₹3.04 Cr | -73.8% | 89.0% | 8 | Hubli, Karnataka, India |
| Lexicare Pharma Private Limited | ₹4.11 Cr (FY 2025) | -5.0% | Ankleshwar, Gujarat, India | |||
| Om Sai Suppliers Private Limited | ₹4.1 Cr (FY 2022) | Mumbai, Maharashtra, India | ||||
| S.V. Organics Private Limited | ₹4.1 Cr (FY 2025) | -32.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Elegant Drugs Private Limited, buy the company report.
Auditor
Elegant Drugs Private Limited is audited by D Sumermal Ostwal & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D Sumermal Ostwal & Co | FY 2023 | 24449 |
Shareholding
The shareholding of Elegant Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elegant Drugs Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Nov 2009 | 10190982 | Axis Bank Limited | ₹2.6 Cr | Open | |
| 15 Sep 2008 | 10121952 | Punjab National Bank | ₹13.5 Lakh | Satisfied | |
| 31 May 2006 | 10006619 | Punjab National Bank | ₹12.98 Lakh | Satisfied | |
| 13 Mar 2005 | 90198570 | Punjab National Bank | ₹3.43 Lakh | Satisfied | |
| 31 Mar 1997 | 90198989 | Punjab National Bank | ₹70 Lakh | Satisfied |
To see the full charge records of Elegant Drugs Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Elegant Drugs Private Limited has 39 court cases on record: 24 filed by Elegant Drugs, 15 filed against it. 4 cases are pending and 35 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 8 | 2 |
| High courts | 16 | 7 | 2 |
Cases on record (5 of 39)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Court case (Spl .Dkst) | Filed by the company against Hindustan Antibiotics Ltd. | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against M/S Global Medikit Limited and 5 others | Disposed |
| High Court of Karnataka | Writ petition | Filed against the company by Mahendra Labs Private Limited | Disposed |
| District court, DHARWAD, Karnataka | Court case (R.A.) | Filed by the company against Hindustan Antibiotics Ltd, | Disposed |
| High Court of Karnataka | Appeal | Filed against the company by M/S Nestor Pharmaceuticals Ltd | Disposed |
To see the full case history of Elegant Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elegant Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Elegant Drugs Private Limited has a workforce of 8 employees on its EPFO records as of Oct 08, 2025, across 1 active EPFO establishment.
GST
Elegant Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAACE3971B1ZU | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Elegant Drugs Private Limited, buy the company report.
Recent activity
Elegant Drugs Private Limited has 6 board changes on record since 1997: 4 appointments and 2 cessations. The latest: Koteswara Rao Yechuri ceased to be Additional Director on 29 Sep 2022.
12 earlier events are in the company report.
Frequently asked questions
Elegant Drugs is an active private limited company based in Hubli, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 August 1988 (38+ years old) and is registered under CIN U02423KA1988PTC009345.
Elegant Drugs has 3 current directors:
- Rajashekar Channasangappa Pattanashetti - Managing Director
- Seetha Raman Subramaniyam - Director
- Koteswara Rao Yechuri - Director
The latest financial statements of Elegant Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Elegant Drugs is 29AAACE3971B1ZU, registered in Karnataka.
The CIN (Corporate Identification Number) of Elegant Drugs is U02423KA1988PTC009345. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elegant Drugs has 39 court cases on record: 24 filed by the company and 15 filed against it. 4 are pending. Most are in the district courts.
Elegant Drugs was incorporated on 08 August 1988, making it 38+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Elegant Drugs by revenue are Dales Laboratories P Ltd, Lexicare Pharma Private Limited, Om Sai Suppliers Private Limited, S.V. Organics Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Koteswara Rao Yechuri ceased to be Additional Director on 29 Sep 2022. Seetha Raman Subramaniyam ceased to be Additional Director on 29 Sep 2022. Koteswara Rao Yechuri was appointed as Director on 13 Jan 2022. Elegant Drugs has 6 board changes on record in total.
Elegant Drugs can be reached through the website elegantdrugs.com. Its registered office is in Hubli, Karnataka, India.
The registered office of Elegant Drugs is at R.S. No.593A Chalamatti Village Sarwar Road Hubli, Karnataka, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
